Using Graphics Processor Units (GPUs) for automatic video structuring

The rapid pace of development of Graphic Processor Units (GPUs) in recent years in terms of performance and programmability has attracted the attention of those seeking to leverage alternative architectures for better performance than that which commodity CPUs can provide. In this paper, the potential of the GPU in automatically structuring video is examined, specifically in shot boundary detection and representative keyframe selection techniques. We first introduce the programming model of the GPU and outline the implementation of techniques for shot boundary detection and representative keyframe selection on both the CPU and GPU, using histogram comparisons. We compare the approaches and present performance results for both the CPU and GPU. Overall these results demonstrate the significant potential for the GPU in this domain

A user-centered approach to rushes summarisation via highlight-detected keyframes

We present our keyframe-based summary approach for BBC Rushes video as part of the TRECVid Summarisation benchmark evaluation carried out in 2007. We outline our approach to summarisation that uses video processing for feature extraction and is informed by human factors considerations for summary presentation. Based on the performance of our generated summaries as reported by NIST, we subsequently undertook detailed failure analysis of our approach. The findings of this investigation as well as recommendations for alterations to our keyframe-based summary generation method, and the evaluation methodology for Rushes summaries in general, are detailed within this paper

Overcoming the barriers to e-cluster development in a low product complexity business sector

Purpose – The purpose of this paper is to investigate the issues that impact negatively on e-cluster development in a low product complexity industry and identification of key factors to overcome the barriers. Design/methodology/approach – Structured interviews were used to identify perceived value and user expectations from e-clusters. Workshops involving assessment of a prototype e-cluster validated user expectations. A mapping study and best practice review provided a basis for e-cluster application development and assessing potential industry uptake. Findings – Interest and perceived value of e-clusters varied according to size of organisation with smaller organisations primarily interested in e-connectivity to retailers and e-business development. Organisations of all sizes, however, indicated a willingness to learn from each other and partner although level of e-connectivity was average and overall level of sophistication was low. Practical implications – Industrial review and acceptance of a prototype e-cluster that would enable organisations manage several critical aspects of their operations from a single interface. Originality/value – The paper provides new understanding of key issues that impact the operational benefits of e-clusters and, in particular, factors that would underpin the success of e-cluster success in a competitive, insular, low product complexity industry. This presents an informed basis for e-cluster managers and members to successfully manage their initiative

The effect of endothelial cell overexpression of plasminogen activator inhibitor-1 on smooth muscle cell migration

AbstractIntroduction: Plasminogen activator inhibitor-1 (PAI-1), a known inhibitor of plasminogen activators, may regulate smooth muscle cell migration (SMC) through alteration in matrix metalloproteinase (MMP) activity. Methods: To study the effect of endothelial cell (EC) PAI-1 overexpression on SMC migration, RT-PCR was used to clone the full length PAI-1 gene, which was ligated into the pCMV/myc/ER expression vector. With electroporation, bovine aortic ECs were transfected with either the PAI-1 construct or the empty vector as control. EC PAI-1 overexpression was shown with a specific PAI-1 activity assay and enzyme-linked immunosorbent assay. The effect of EC PAI-1 overexpression on SMC migration was measured with a modified Boyden-chamber assay. SMC MMP expression was measured with zymography. Results: Selected clones (EC9, EC21) had a three-fold to five-fold increase in PAI-1 activity compared with untransfected EC and empty vector EC (ECC). Similarly, enzyme-linked immunosorbent assay results showed a 3.5-fold to 5.5-fold increase in PAI-1 levels in EC9 and EC21 versus ECC. Untransfected EC and ECC had similar effects on SMC migratory patterns. Migration of SMC exposed to PAI-1 overexpressing EC was inhibited by 35% to 57% compared with ECC. This inhibitory effect was reversed with addition of exogenous urokinase-type plasminogen activator (uPA). Zymography showed downregulation of MMP-2 and MMP-9 in SMCs exposed to PAI-1 overexpressing EC. Conclusion: PAI-1 overexpression with transfected EC inhibits SMC migration. This effect may be mediated through decreased SMC MMP activity. (J Vasc Surg 2002;36:164-71.

Blood type gene locus has no influence on ACE association with Alzheimer's disease

The ABO blood group locus was recently found to contribute independently as well as via interactions with ACE gene variation to plasma levels of angiotensin converting enzyme (ACE). Variation in ACE has also previously been implicated as conferring susceptibility for Alzheimer’s disease (AD), but has also been proposed to confer risk via interactions with other as yet unknown genes. More recently, larger studies have not supported ACE as a risk factor for AD, while the role of ACE pathway in AD has come under increased levels of scrutiny with respect to various aspects of AD pathology and possible therapies. We explored the potential combined involvement of ABO and ACE variation in the genetic susceptibility of 2067 AD cases compared to 1376 non-demented elderly. Including the effects of ABO haplotype did not provide any evidence for the genetic association of ACE with AD

Metabolomic Profiling of Bile Acids in Clinical and Experimental Samples of Alzheimer’s Disease

Certain endogenous bile acids have been proposed as potential therapies for ameliorating Alzheimer’s disease (AD) but their role, if any, in the pathophysiology of this disease is not currently known. Given recent evidence of bile acids having protective and anti-inflammatory effects on the brain, it is important to establish how AD affects levels of endogenous bile acids. Using LC-MS/MS, this study profiled 22 bile acids in brain extracts and blood plasma from AD patients (n = 10) and age-matched control subjects (n = 10). In addition, we also profiled brain/plasma samples from APP/PS1 and WT mice (aged 6 and 12 months). In human plasma, we detected significantly lower cholic acid (CA, p = 0.03) in AD patients than age-matched control subjects. In APP/PS1 mouse plasma we detected higher CA (p = 0.05, 6 months) and lower hyodeoxycholic acid (p = 0.04, 12 months) than WT. In human brain with AD pathology (Braak stages V-VI) taurocholic acid (TCA) were significantly lower (p = 0.01) than age-matched control subjects. In APP/PS1 mice we detected higher brain lithocholic acid (p = 0.05) and lower tauromuricholic acid (TMCA; p = 0.05, 6 months). TMCA was also decreased (p = 0.002) in 12-month-old APP/PS1 mice along with 5 other acids: CA (p = 0.02), β-muricholic acid (p = 0.02), Ω-muricholic acid (p = 0.05), TCA (p = 0.04), and tauroursodeoxycholic acid (p = 0.02). The levels of bile acids are clearly disturbed during the development of AD pathology and, since some bile acids are being proposed as potential AD therapeutics, we demonstrate a method that can be used to support work to advance bile acid therapeutics

SN~2012cg: Evidence for Interaction Between a Normal Type Ia Supernova and a Non-Degenerate Binary Companion

We report evidence for excess blue light from the Type Ia supernova SN 2012cg at fifteen and sixteen days before maximum B-band brightness. The emission is consistent with predictions for the impact of the supernova on a non-degenerate binary companion. This is the first evidence for emission from a companion to a SN Ia. Sixteen days before maximum light, the B-V color of SN 2012cg is 0.2 mag bluer than for other normal SN~Ia. At later times, this supernova has a typical SN Ia light curve, with extinction-corrected M_B = -19.62 +/- 0.02 mag and Delta m_{15}(B) = 0.86 +/- 0.02. Our data set is extensive, with photometry in 7 filters from 5 independent sources. Early spectra also show the effects of blue light, and high-velocity features are observed at early times. Near maximum, the spectra are normal with a silicon velocity v_{Si} = -10,500$ km s^{-1}. Comparing the early data with models by Kasen (2010) favors a main-sequence companion of about 6 solar masses. It is possible that many other SN Ia have main-sequence companions that have eluded detection because the emission from the impact is fleeting and faint.Comment: accepted to Ap

Next generation sequencing of CLU, PICALM and CR1: pitfalls and potential solutions

CLU, PICALM and CR1 were identified as genetic risk factors for late onset Alzheimer’s disease (AD) in two large genome wide association studies (GWAS) published in 2009, but the variants that convey this alteration in disease risk, and how the genes relate to AD pathology is yet to be discovered. A next generation sequencing (NGS) project was conducted targeting CLU, CR1 and PICALM, in 96 AD samples (8 pools of 12), in an attempt to discover rare variants within these AD associated genes. Inclusion of repetitive regions in the design of the SureSelect capture lead to significant issues in alignment of the data, leading to poor specificity and a lower than expected depth of coverage. A strong positive correlation (0.964, p<0.001) was seen between NGS and 1000 genome project frequency estimates. Of the ~170 “novel” variants detected in the genes, seven SNPs, all of which were present in multiple sample pools, were selected for validation by Sanger sequencing. Two SNPs were successfully validated by this method, and shown to be genuine variants, while five failed validation. These spurious SNP calls occurred as a result of the presence of small indels and mononucleotide repeats, indicating such features should be regarded with caution, and validation via an independent method is important for NGS variant calls